This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
A Research Study to Investigate the Effects of CagriSema Compared to Placebo in People With Type 2 Diabetes and Painful Diabetic Peripheral Neuropathy | MicrobiomeTrials
← Back to trials NCT06797869
A Research Study to Investigate the Effects of CagriSema Compared to Placebo in People With Type 2 Diabetes and Painful Diabetic Peripheral Neuropathy Completed PHASE2 INTERVENTIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2025-01-29Est. Completion: 2026-06-26
Enrollment target: 142 participantsLocations eStudySite, La Mesa, California, United States Linda Vista Health Care Ctr, San Diego, California, United States My Preferred Research, Miami, Florida, United States New Horizon Research Center, Miami, Florida, United States Renstar Medical Research, Ocala, Florida, United States Renstar Medical Research, Ocala, Florida, United States Foot & Ankle Center of Illinois, Springfield, Illinois, United States Velocity Clinical Research Rockville, Rockville, Maryland, United States Amicis Centers of Clinical Research, St Louis, Missouri, United States DM Clinical, Albuquerque, New Mexico, United States Southgate Medical Group, LLP, West Seneca, New York, United States Piedmont Healthcare/Research, Statesville, North Carolina, United States Lillestol Research LLC, Fargo, North Dakota, United States Oregon Health & Science University, Portland, Oregon, United States Clinical Res Collaborative, Cumberland, Rhode Island, United States DM Clinical, Houston, Texas, United States Other microbiome trials you might be interested in Type 2 Diabetes Mellitus (T2DM)
This randomized controlled trial will evaluate the effect of digital-supported foot care education on foot care knowledg…
Siirt, Turkey (Türkiye) Est. completion Jul 15, 2027
Type 1 Diabetes (T1D)
Islet transplantation restores glucose tolerance in people living with diabetes characterised by high glycaemic variabil…
Strasbourg, France Est. completion Jan 2032
Radiance Clinical Research, Lampasas, Texas, United States
DM Clinical Research, San Antonio, Texas, United States
DM Clinical, San Antonio, Texas, United States
Velocity Clinical Research Portsmouth, Suffolk, Virginia, United States
G.A. Research Associates Ltd., Moncton, New Brunswick, Canada
Centricity Research Brampton Endocrinology, Brampton, Ontario, Canada
Centricity Clinical Research Burlington, Burlington, Ontario, Canada
Centricity Research Etobicoke Endocrinology, Etobicoke, Ontario, Canada
Premier Clinical Trial Research Network (PCTRN), Hamilton, Ontario, Canada
Diabetes Heart Research Centre, Toronto, Ontario, Canada
Ctr de Med Metab de Lanaudiere, Terrebonne, Quebec, Canada
Aarhus Universitetshospital, Steno Diabetes Center Aarhus, Aarhus N, Denmark
Steno Diabetes Center Nordjylland, Gistrup, Denmark
Steno Diabetes Center Copenhagen, Herlev, Denmark
Kolding Sygehus Karkirurgi, Kolding, Denmark
Steno Diabetes Center Odense, Odense C, Denmark
Les Hopitaux de Chartres-Hopital Louis Pasteur, Le Coudray, France
Groupe Sos Sante-Hopital Le Creusot-Hotel Dieu, Le Creusot, France
Aphp-Hopital La Pitie Salpetriere, Paris, France
Centre Hospitalier Universitaire de Bordeaux-Hopital Haut Leveque, Pessac, France
Centre de Recherche Clinique Portes Du Sud, Vénissieux, France
Haukeland Universitetssykehus, Bergen, Norway
Sykehuset Innlandet HF Hamar, Hamar, Norway
Oslo universitetssykehus, Ullevål, Oslo, Norway
Stavanger Universitetssykehus, Helse Stavanger HF, Stavanger, Norway
Hospital Nisa Sevilla Aljarafe (To be inactivated when NN9388-7864 is in closing status), Castilleja de la Cuesta, Andalusia, Spain
Hospital Germans Trias i Pujol, Badalona, Barcelona, Spain
Complejo Hospitalario Universitario A Coruña, A Coruña, Spain
Hospital Vall d'Hebron, Barcelona, Spain
Hospital Universitario de la Princesa, Madrid, Spain
Hospital Universitario Marqués de Valdecilla, Santander, Spain
H. Infanta Luisa_Endocrino y Obesidad, Seville, Spain
Tameside General Hospital, Ashton-under-Lyne, Greater Manchester, United Kingdom
Ipswich Hospital - Diabetes, Ipswich, United Kingdom
Aintree University Hospital, Liverpool, United Kingdom
St Pancras Clinical Research, London, United Kingdom
King's College Hospital - Renal, London, United Kingdom
Manchester Royal Infirmary - Diabetes, Manchester, United Kingdom
Royal Hallamshire Hospital, Sheffield, United Kingdom Cardiometabolic Risk Factors Mental Health
Background:
As of 2021, almost 45 million people in the United States were foreign-born immigrants. South Asians, inclu…
Columbus, United States Est. completion Aug 31, 2027